Correlation Between Pieris Pharmaceuticals and Neurosense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Neurosense Therapeutics, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Neurosense Therapeutics.

Diversification Opportunities for Pieris Pharmaceuticals and Neurosense Therapeutics

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pieris and Neurosense is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between Pieris Pharmaceuticals and Neurosense Therapeutics

Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to generate 0.58 times more return on investment than Neurosense Therapeutics. However, Pieris Pharmaceuticals is 1.73 times less risky than Neurosense Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Neurosense Therapeutics is currently generating about -0.43 per unit of risk. If you would invest  1,700  in Pieris Pharmaceuticals on August 30, 2024 and sell it today you would lose (17.00) from holding Pieris Pharmaceuticals or give up 1.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pieris Pharmaceuticals  vs.  Neurosense Therapeutics

 Performance 
       Timeline  
Pieris Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Neurosense Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Neurosense Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pieris Pharmaceuticals and Neurosense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pieris Pharmaceuticals and Neurosense Therapeutics

The main advantage of trading using opposite Pieris Pharmaceuticals and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.
The idea behind Pieris Pharmaceuticals and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Managers
Screen money managers from public funds and ETFs managed around the world